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A 43 kDa phospholipase C-activating protein has been purified
previously from turkey erythrocytes and shown to express
immunological properties expected of that of the Gq family of
G-protein a-subunits [Waldo, Boyer, Morris and Harden (1991)
J. Biol. Chem. 266, 14217-14225]. Internal amino acid sequence
has now been obtained from this protein which shares 50-100%
sequence identity with sequences encoded by mammalian Gall
and Gaq cDNAs. To identify the purified protein unambiguously,
it was necessary to compare its amino acid sequence with the
sequence encoded by avian G-protein a-subunit cDNA. As such,
mouse Gaq was used as a probe to screen turkey brain and fetal-
turkey blood cDNA libraries. A full-length cDNA was identified
INTRODUCTION
G-proteins are heterotrimeric signalling proteins that couple a
broad range of cell-surface receptors to second-messenger-regu-
lating enzymes and to ion channels [1,2]. Although involvement
of G-proteins in receptor-regulated inositol lipid signalling has
been indirectly suggested for the last decade, progress in identi-
fying these proteins has been reported only recently.
Proteins have been purified from detergent extracts of bovine
brain [3,4], bovine liver [5,6] and turkey erythrocyte [7] mem-
branes that confer AIF4-- and guanine-nucleotide-mediated regu-
lation to phospholipase C. Immunoreactivity of these proteins
with G-protein-selective antisera suggests that they are members
of the Gq family of proteins initially identified by molecular
cloning by Simon and colleagues ([8,9]; for review see [10]). On
the basis of partial amino acid sequence, the preparation from
brain was shown to consist of Gaq and some Gall [3]. The liver
preparation contained 42 and 43 kDa proteins expressing
immunoreactivity consistent with Gaq and Gall respectively
[5,6].
Turkey erythrocytes have provided a useful homogeneous cell
preparation for the study of inositol lipid signalling [1 1]. We have
purified the G-protein-regulated form of phospholipase C from
this source [12,13] and have used this enzyme to purify a 43 kDa
phospholipase C-activating protein [7]. We now report internal
amino acid sequence and molecular cloning of the cDNA for the
avian G-protein that unambiguously confirm that this phos-
pholipase C-activating protein is Gall. Also, using an insect cell
expression system, we demonstrate that the protein encoded by
the cDNA is recognized by Ga1l-selective antisera and that it
activates purified avian erythrocyte phospholipase C.
EXPERIMENTAL
Materials
Q-Sepharose Fast Flow, Sephacryl S-300HR, octyl-Sepharose,
that encodes avian Ga11, on the basis of its 96-98% amino
acid identity with mammalian Gail. All eight peptides sequenced
from the turkey erythrocyte phospholipase C-activating protein
are completely contained within the deduced amino acid sequence
of the avian Gall cDNA. Expression of this cDNA in Sf9 cells by
using a baculovirus expression system resulted in the production
of a 43 kDa protein that reacts strongly with antisera to the Gq
family of G-protein a-subunits and activated purified avian
phospholipase C in an AlF4--dependent manner. Taken together,
these results unambiguously identify the protein purified from
turkey erythrocytes, on the basis of its capacity to activate avian
phospholipase C, as Ga.ll
heparin-Sepharose, Protein A-Sepharose, Sephadex G-50F and
Mono Q HR5/5 were obtained from Pharmacia (Piscataway,
NJ, U.S.A.). Bio-Gel HTP hydroxyapatite and the HPTP column
were from Bio-Rad Laboratories (Richmond, CA, U.S.A.).
Vydac C-4 (214-TP546) and C-18 (218-TP546) reverse-phase
h.p.l.c. columns were from Rainin (Emeryville, CA, U.S.A.).
Phosphatidylserine and phosphatidylethanolamine were from
Avanti Polar Lipids (St. Louis, MO, U.S.A.). CHAPS was
purchased from Pierce (Rockford, IL, U.S.A.), and sodium
cholate (Sigma, St. Louis, MO, U.S.A.) was purified as previously
described [7]. [3H]Inositol was from American Radiolabelled
Chemicals, and [3H]PtdIns4P and [3H]Ptdlns(4,5)P2 were purified
from [3H]inositol-labelled turkey erythrocytes as previously de-
scribed [12]. Unlabelled PtdIns(4,5)P2 and PtdIns4P were purified
from bovine brain as previously reported [12]. The cDNA
synthesis and cloning systems (A ZAP) were purchased from
Stratagene, and the Sequenase DNA-sequencing kits were from
U.S. Biochemical Corp. [32P]dCTP and [35S]dATP were from
Amersham. Nitrocellulose filters were from Schleicher & Schuell
(Keene, NH, U.S.A.). Strepavidin-conjugated paramagnetic
beads were from Promega (Madison, WI, U.S.A.). Sea Kem
GTG agarose was from FMC BioProducts (Rockland, ME,
U.S.A.) and the Qiaex resin was from Qiagen Inc. (Chatsworth,
CA, U.S.A.). Vector pVL1392 and linear AcNPV viral DNA
were from Invitrogen (San Diego, CA, U.S.A.). Antisera W082
and E976 were generously provided by Dr. Paul Sternweis and
Dr. John Exton, respectively. Rabbit polyclonal antiserum 118
was generated in our laboratory against the haemocyanin-
coupled synthetic peptide CILQLNLKEYNL, which corres-
ponds to the C-terminal sequence of both Gaq and Gal1.
Purfflcation and trypsin treatment of the 43 kDa turkey
erythrocyte phospholipase C-activating protein
G-protein-regulated phospholipase C [12,13] and the 43 kDa
phospholipase C-activating protein [7] were purified from turkey
Abbreviation used: TFA, trifluoroacetic acid.
* To whom correspondence should be addressed.
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Figure 1 Immunoblot analysis of the 43 kDa phospholipase C-activating
protein purified from turkey erythrocytes
Purified phospholipase C-activating protein (40 ng/lane) was subjected to SDS/PAGE and
transferred to nitrocellulose for Western-blot analysis (see the Experimental section). Antiserum
118 was raised against a sequence common to Gacq and Ga11; E976 was raised against a
sequence unique to Ga11; W082 was raised against a sequenceunique to Gaq; The 27-60 kDa
region for each immunoblot is shown and the antisera used for immunodetection are listed at
the top. Mobility of molecular-mass standards (kDa) is indicated on the left.
erythrocytes. Protease inhibitors and minor contaminants in-
cluding fy-subunits were removed from the 43 kDa phospho-
lipase C-activating protein by C-4 reverse-phase h.p.l.c. before
trypsin treatment. Briefly, the purified phospholipase C-acti-
vating protein pool was exchanged from buffer A (25 mM Tris,
pH 7.5, 1 mM dithiothreitol, 50 #M AlCl3, 10 mM NaF, 3 mM
MgCl2, 30 ,iM GDP, 0.1 mM benzamidine, 20 ,ug/ml phenyl-
methanesulphonyl fluoride, 1 jtg/ml leupeptin, 1 /tg/ml apro-
tinin, 1 /tg/ml pepstatin and 0.6% CHAPS) to buffer B (20 mM
Tris, pH 7.5, and 0.1 % Lubrol) by chromatography on a Mono-
Q 5/5 f.p.l.c. column and elution of the protein with buffer B
containing 400 mM NaCl. After addition of 0.1 0% trifluoroacetic
acid (TFA), the Mono-Q eluate was loaded on a Vydac C-4
h.p.l.c. column at 1 ml/min and eluted with a linear gradient of
water (+ 0.1 % TFA) to acetonitrile/propan-2-ol (3: 1, v/v)
(+ 0.1 % TFA) over 60 min. Fractions containing the 43 kDa
protein, as determined by silver staining of SDS/PAGE and
Western-blot analysis using antiserum 118, were pooled (approx.
10 ,ug) and dried in a polypropylene microfuge tube by rotary
evaporation under vacuum. The protein was resuspended in
100 4ul of 1 % NH4HCO3, pH 8.0, and digested for 10 h at 37 °C
at a trypsin/protein ratio of 1:50 (w/w). Tryptic peptides were
resolved by h.p.l.c. on a Vydac C-18 h.p.l.c. column developed
with a 180 min linear gradient of water (+ 0.1 % TFA) to 100%
acetonitrile (+ 0.1% TFA) at 0.5 ml/min. Peaks of absorbance
at 214 and 280 nm selected for amino acid analysis were further
purified by C-18 chromatography, with elution with a linear
gradient of water (0.1 0% TFA) to 50% acetonitrile (0.1 % TFA)
over 180 min at a flow rate of 1 ml/min. Purified fractions were
concentrated by rotary evaporation and subjected to sequence
analysis on an Applied Biosystems 475A Protein Sequencer. The
yields of amino acids during peptide sequencing ranged from 20
to 80 pmol.
Reconstitution assay
G-protein-regulated phospholipase C activity was measured by a
modification of the method described by Waldo et al. [7]. Briefly,
lipids {200 ,uM phosphatidylserine, 800 ,#M phosphatidyl-
ethanolamine and 200 4uM [3H]PtdIns(4,5)P2} were dispersed by
sonication in a buffer containing 20 mM Hepes, pH 7.4, 2 mM
MgCl2, 100 mM NaCl, 1 mM dithiothreitol and 1.20% sodium
cholate. Extracts from Sf9-cell membranes (in 1.2% cholate)
were added to the resuspended lipids and vesicles were formed by
dialysis against the above buffer (minus cholate). Assays were
initiated by addition of phospholipase C (10 ng) in a buffer
containing 57.5 mM Hepes, pH 7.0, 75 mM NaCl, 4 mM MgCl2,
2 mM EGTA, 0.5 mg/ml BSA and CaCl2 to yield a free [Ca21] of
3.4,uM. Reactions were terminated by addition of chloroform/
methanol/HCl (20:40: 1, by vol.)
Gel electrophoresis and immunoblots
SDS/PAGE was performed on gels of 8.5 % acrylamide/0.5 °h
bisacrylamide as previously described [7].
Construction of fetal turkey blood and turkey brain cDNA
libraries
The tissues were prepared as follows. Fifty 9-11-day-incubated
turkey eggs were obtained, the eggs were opened and the chorionic
membrane and its associated vasculature were dissected, minced
and placed in ice-cold isotonic saline. The minced tissue was
strained through cheesecloth, and blood cells were collected from
the filtrate by centrifugation. The cells were washed twice in ice-
cold isotonic saline. The brain of an adult female turkey was
removed, cleaned and immediately placed in liquid nitrogen. The
frozen tissue was then powdered. RNA was isolated from fetal
turkey blood and turkey brain by the method of Chomczynski
and Sacchi [14]. Briefly, RNA was extracted from the pelleted
blood cells and frozen brain tissue, and polyadenylated RNA
was isolated from the totalRNA by using a biotinylated oligo(dT)
probe and a magnetic separation system employing strepavidin-
conjugated paramagnetic beads, by following the manufacturer's
suggested procedures, except that the annealing reaction was
performed in 3.5 x SSC (1 x SSC = 0.15 M NaCl/ 15 mM sodium
citrate).
cDNA synthesis was performed by using 27 ,tg of fetal turkey
blood RNA and 15 ,ug ofturkey brain RNA. ThecDNA synthesis
reactions essentially followed the method ofGubler and Hoffman
[15], with the substitution of methyl-dCTP for CTP, and were
primed with an oligo(dT)-containing adaptor-primer which
introduced a XhoI restriction site into the 3' end of the newly
synthesized double-stranded cDNA. After ligation with EcoRI
adaptors and phosphorylation of the adaptor ends, the cDNA
was cleaved with XhoI and resolved from unligated adaptors and
size-fractionated by electrophoresis on a 1% low-melting-
agarose gel. cDNA of the desired size class (1-2 kb for the fetal
turkey blood cDNA and > 1 kb for the turkey brain cDNA) was
recovered from the melted gel slices by using Qiaex resin. Approx.
200 ng of each cDNA preparation was ligated with 1 4ug of
EcoRI/XhoI-digested A ZAP and the resulting preparations were
packaged to yield functional cDNA libraries. The unamplified
fetal turkey blood 1-2 kb cDNA library contained 1.5 x 106
plaque-forming units, and when amplified contained 94% recom-
binant bacteriophage. The unamplified turkey brain > 1 kb
cDNA library contained 1.4 x 106 plaque-forming units, and
when amplified contained 96% recombinant bacteriophage.
Isolation of cDNA
Approx. 106 recombinants were screened by high-stringency






































Figure 2 Trypsin treatment and amino acid analysis of the 43 kDa phospholipase C-activating protein purified from turkey erythrocytes
(a) Silver-stained SDS/PAGE of 60 ng of the purified turkey erythrocyte phospholipase C-activating protein before trypsin treatment. The mobility of molecular-mass standards (kDa) is indicated.
(b) H.p.l.c. of peptides generated by trypsin treatment of 10 ,ug of purified turkey erythrocyte phospholipase C-activating protein (see the Experimental section). Absorbance of trypsin alone is also
indicated (- -). Peptides for which the amino acid sequence was determined are numbered. (c) Partial amino acid sequence comparison of turkey erythrocyte phospholipase C-activating protein
and a-subunits of members of the Gq family of G-proteins. Identical amino acids are indicated by (-), and different amino acids are shown.
5 x SSC/0.5 % SDS/l mM EDTA at 42 0C for 2 h. Filters were
incubated at 42 0C for 2 h in 100 ml of a prehybridization
solution that consisted of 0.8 M NaCl, 0.02 M Pipes, pH 6.8,
0.25 % SDS, 50% formamide and 100 pug/ml denatured salmon
sperm DNA. Filters were probed with 25 ng of [32P]dCTP-
labelled mouse Gaq that contained the entire coding sequence
as well as 3' and 5' untranslated sequences. The probe (approx.
1 x 109 c.p.m./,ug) was hybridized to the nitrocellulose filters for
16-24 h at 42 0C in 50 ml of a solution identical with that used
in the prehybridization step. Filters were washed in 2 x SSC/
0.1% SDS for 4 x 5 min at room temperature and then for
2 x 1 h in 1 x SSC/0.1 % SDS at 68 'C. Positive plaques were
purified and pBluescript was rescued from A-phage DNA ac-
cording to the manufacturer's recommendations. Inserts were
subcloned into bacteriophage M1 3 (mpl8 and mpl9), and both
strands were sequenced by using primers which yielded over-
lapping sequences.
Expression of avian Ga1, in Sf9 Insect cells
cDNA B4 was subcloned into the EcoRI/Smal sites of the
pVL1392 transfer vector. After co-transfection of Sf9 cells with
this construct and linear Autographa californica nuclear-poly-
hedrosis-virus DNA, recombinant viral stock was made by
established procedures [16], after selection on the basis of the
occ- phenotype. The plaque pure virus was used to infect ad-
herent Sf9 cells at a multiplicity of approx. 1. Adherent cells
were grown at 27 0C for 72-96 h, suspended and collected by
centrifugation (500 g, 5 min). Lysis was by resuspension in ice-
cold lysis buffer containing 1 mM NaHCO3, 2 mM CaCl2, 5 mM
MgCl2, 10 mM Tris, pH 7, 0.1 mM benzamidine, 0.1 mM
phenylmethanesulphonyl fluoride and homogenization with
15-20 strokes in a Wheaton-type Dounce homogenizer.
Intact nuclei and non-lysed cells were pelleted by centrifugation
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1/1
ATG ACT CTG GAG TCC ATG ATG
Met thr leu glu ser met met
61/21
ATC AAT GCC GAG ATC GAA AAG
ile asn ala glu ile glu lys
121/41
AAA CTG CTG CTG TTG GGC ACT
lys leu leu leu leu gly thr
181/61
ATC ATT CAT GGC TCA GGC TAC
ile ile his gly ser gly tyr
241/81
CAA AAC ATC TTC ACT GCC ATG
aln asn ile ohe thr ala met
301/101
TAC AAA TAC GAG CAG AAC AAG
tyr lys tyr glu gln asn lys
361/121
GTC ATG ACA ITTT GAG CAG CCC
val met thr Dhe alu gln pro
421/141
ATA CAG GAG TGT TAT GAC AGA
ile gln glu cys tyr asp arg
481/161
CTC AGC GAC GTG GAT CGT ATC
leu ser AS2 val asp arg ile
541/181
CGG GTT CGA GTT CCT ACG ACT
arg val arg val pro thr thr
601/201
TTC AGA ATG GTG GAT GTT GGA
phe arg met val asp val gly
661/221
GAA AAT GTG ACT TCC ATC ATG
glu asn val thr ser ile met
721/241
GAG TCT GAT AAT GAG AAC CGG
glu ser asp asn glu asn arg
781/261
TAT CCC TGG TTC CAA AAC TCA
tyr pro trp phe gln asn ser
841/281
GAC AAG ATC CTC TAT TCC CAT
asp lys ile leu tyr ser his
901/301
GAC GCG CAG GCA GCC CGC GAG
asp ala gln ala ala arg gll,
961/321
GAC AAA ATC ATC TAC TCC CAC
asp lys ile ile tyr ser his
1021/341
TTC GCG GCC GTG AAG GAC ACC
ohe ala ala val lvs asp thr
GCA CGA GGA GGA CCG GAG
31/11
GCT TGT TGC CTG AGC GAC
ala cys cys leu ser asp
91/31
CAG CTG CGG AGG GAC AAA
gln leu arg arg asp lys
151/51
GGG GAG AGT GGA AAA AGC
gly glu ser gly lys ser
211/7 1
TCT GAA GAG GAC AAA AAA
ser glu glu asp lys lys
271/91
CAG TCC ATG ATC AGG GCC
aln ser met ile ara ala
331/111
GCC AAC GCA GTC CTO ATC
ala asn ala val leu ile
391/131
TAC GTA AGT GCA ATT AAA
tvr val ser ala ile lys
451/151
AGA AGA GAA TAC CAA CTT
arg arg glu tyr gln leu
511/171
GCT ACC CCA GGA TAT CTA
ala thr pro gly tvr lu
571/191
GGG ATC ATA GAG TAC CCC
gly ile ile glu tyr pro
631/211
GGT CAG AGA TCA GAA CGG
gly gln arg ser glu arg
691/23 1
CGT CCC GGC GGC GTC TTT ACC
GAG GTG AAA GAG TCG AAA CGA
glu val lys glu ser lys arg
CGC GAC GCA CGG CGA GAG CTG
arg asp ala arg arg glu leu
ACG TTC ATT AAG CAG ATG CGT
thr phe ile lys gln met arg
GGT TTT ACC AAG CTG GTA TAT
gly phe thr lys leu val tyr
ATG GAA ACC CTG AAG ATT CTG
met glu thr leu lys ile leu
CGG GAG GTG GAT GTA GAA AAG
arg glu val asp val glu lys
ACC TTG TGG AAC GAC CCT GGA
thr leu trp asn asp pro gly
TCT GAT TCA GCT AAA TAC TAT
ser asp ser ala lys tyr tyr
CCA ACT CAG CAA GAT GTG CTA
n-rn t-hr "In "In Acn ttAt v1 1i
TTT GAC CTA GAG AAT ATT ATC
phe asp leu glu asn ile ile
AGG AAG TGG ATC CAT TGC TTT
arg lys trp ile his cys phe
TTA GTA GCA CTT AGT GAA TAT GAC CAA GTT CTG GTG
leu val ala leu ser glu tyr asp gln val leu val
751/251
GAA GAG AGT AAA GCC CTC TTC CGA ACC ATT ATC ACC
glu glu ser lys ala leu ohe ara thr ile ile thr
811/271
GTT ATC CTC TTT CTG AAC AAG AAG GAT CTG TTG GAA
val ile leu phe leu asn lys lys asp leu leu glu
87 1/291
OTT GAC TAT TTC CCA GAG TTT GAT GGC CCG CAG AGG
val asp tyr phe pro glu phe asp gly pro gln arg
931/311
ATC CTC AAG ATG TTT GTG GAT TTG AAT CCA GAC AGT
ile leu lys met phe val asp leu asn pro asp ser
991/331
ACG TGT GCC ACG GAC ACC GAG AAC ATC CGC TTC GTC
thr cys ala thr asp thr glu asn ile arg Rhe val
1051/351
CTA CAG CTC AAC CTG AAG GAA TAC AAC CTG GTT TGA
leu gln leu asn leu lys alu tvr asn leu val
TCC CCC CCC CCC GCC CCG CCC CTT GGA AAG GAA TCG TTC CTG AAA AGA AAA AGA CAA AAA
AAG GAG AAA AAA AAA AAA AAA AAA GGA ATT AAT TTT AAA CAT GAC CGG AAA AAA AAA CAA
ACA AAA AAA AAA AAA AAA...
Figure 3 Sequence ot clone B4
The entire cDNA sequence was derived from one clone isolated from an oligo(dT)-primed turkey brain cDNA library, by using mouse Gaq as a probe (see the Experimental section). The regions
of deduced amino acid sequence that are identical with the peptide sequence obtained by tryptic digestion of the purified 43 kDa turkey erythrocyte phospholipase C-activating protein are underlined.
of the supernatant obtained after cell lysis at 1000OOg for
30 min.
RESULTS AND DISCUSSION
We have recently reported the purification of a 43 kDa protein
from turkey erythrocytes that, when reconstituted in phospho-
inositide-substrate-containing phospholipid vesicles, confers
AlF4-- and guanosine 5'-[y-thio]triphosphate-sensitivity to puri-
fied avian phospholipase C [7]. The guanosine 5'-[y-thio]-
triphosphate-stimulated activation of the avian phospholipase C,
though small, was blocked by guanosine 5'-[/3-thio]diphosphate
supporting the concept that a G-protein a-subunit is involved
[we have recently purified avian 43 kDa protein that is activated
by GTP[S] and AIF4- to similar extents (G. L. Waldo, un-
published work)]. This purified avian phospholipase C-activating
protein shows strong immunoreactivity with antisera X384 [7]
and 118 (Figure 1), which were generated against the C-terminal
dodecapeptide of Gxq and GGull. Conversely, antiserum W082,
generated against a sequence in Gcxq that is not well conserved in
GcLtx and has been shown to be selective for Gaq [17], recognized
the turkey erythrocyte protein only very weakly (ref. [7]; Figure
1). Antiserum E976 [18] generated against a sequence (amino
acids 160-172) in Gaxl that is not well conserved in Gaq reacted
strongly with the purified 43 kDa turkey erythrocyte protein
(Figure 1). Although the absolute selectivity of E976 has not
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Table 1 ReconstituIlon of purified turkey erythrocyte phospholipase C with
sodium cholate extracts from recombinant-baculovlrus-infected Sf9-cell
membranes
Membranes from baculovirus-infected Sf9 cells were prepared as described in the Experimental
section. Purified avian 43 kDa phospholipase C-activating protein (60 ng), or sodium cholate
extracts of membranes from Sf9 cells infected with recombinant baculoviruses expressing either
f8-galactosidase (1.29 ,sg) or avian G%rj (1.29 ,ug), were combined with dispersed
phospholipids containing [3H]Ptdlns4P, and vesicles were formed by dialysis as described in
the Experimental section. The vesicles were reconstituted with purified turkey erythrocyte
phospholipase C (10 ng) and incubated with either 10 mM Hepes, pH 7.4 (vehicle), or 10 mM
NaF/20 ,sM AICd3 (AIF4-). Assays were for 10 min at 30 OC, and the reactions were terminated
by addition of chloroform/methanol/HCI (20:40:1, by vol.). Values are means+ S.E.M. from













- 5.6 + 5.3
+ 35.1 + 5.5
- 23.5 + 4.2
+ 27.8 + 4.3
- 16.3+6.4
+ 62.6 + 6.2
been assessed, these immunological data are consistent with the
hypothesis that the purified turkey erythrocyte G-protein is
avian Ga.ll However, to identify this protein unequivocally, we
obtained an internal amino acid sequence and cloned its cDNA.
Both of these approaches were considered necessary, since the
members of the Gq family of G-proteins share greater than 80%
amino acid sequence identity [10].
The avian phospholipase C-activating protein was purified as
previously reported [7], with the inclusion of an additional C-4
column step as described in the Experimental section. The
purified 43 kDa protein (Figure 2a) was subjected to cleavage by
trypsin and peptides were purified by reverse-phase h.p.l.c.
(Figure 2b). Sequences from eight peptides were obtained. All
eight sequences were highly (50-100%) similar to sequences
predicted from the deduced amino acid sequences of G-protein
a-subunit cDNA cloned from mouse brain cDNA libraries
(Figure 2c). However, it was not possible to identify the 43 kDa
protein conclusively from this information, or to conclude
categorically that peptides generated from tryptic digests of the
phospholipase C-activating protein were from a single poly-
peptide. Thus, to establish the identity of the avian protein
unambiguously, it was imperative that the avian peptide sequence
be compared with avian cDNA.
A probe made from mouse Gaq cDNA was used to screen an
oligo(dT)-primed turkey brain cDNA library. High-stringency
screening of approx. 106 phages yielded four positive plaques.
Sequence analysis revealed that these four cDNAs were of different
lengths, and that they encoded part of a G-protein a-subunit that
was similar to, though distinct from, Gaq. Further high-strin-
gency screening of the turkey brain cDNA library with the
largest of these cDNAs, 16a, yielded 17 more clones. cDNA B4
was isolated from this second screening. B4 was shown to
contain the entire coding sequence of a Gaq-like protein, in
addition to 5' and 3' untranslated sequences (Figure 3). All
remaining cDNAs isolated from the brain library with clone 16a
had nucleic acid sequences identical with that of B4, though they
were not full length. Similarly, high-stringency screening of an
oligo(dT)-primed fetal turkey blood cDNA library with cDNA
16a resulted in the isolation of seven additional cDNAs. These
cDNAs had nucleic acid sequences identical with those isolated
from the brain library, though none were full length. The longest
of the cDNAs isolated from the blood library comprised nucleo-
tides 125-1259 of clone B4. Since the brain and blood libraries
both yielded cDNAs with identical nucleic acid sequences, and a
full-length version had been isolated from the brain library, no
further attempt was made to isolate a full-length clone from the
blood library.
cDNA B4 encodes a 359-amino-acid protein (Mr 42031)
(Figure 3) that is most similar in sequence to mouse Gall [9] and
its bovine homologue, GLa2 [19]. The similarity between the
amino acid sequence deduced from cDNA B4 and that of mouse
and bovine Ga., is striking. There is only one amino acid
difference in the last 119 amino acids of the C-terminus of B4 and
bovine Ga,,, and the overall identity between the proteins
encoded by these two sequences is 96%. The overall identity
between clone B4 and bovine GLa2 was 98 %, and mouse Gal1
and bovine GLa2 share 97% sequence identity. Similarly, the
deduced amino acid sequence from cDNA B4 shared 91 % and
81 % sequence identity with those of mouse Gaq and Gal4
respectively. Although this similarity is also high, differences
within specific regions of these G-proteins make it highly unlikely
that the cDNA that we report here represents an avian version of
these. The choice of initiating methionine (see Figure 3) was
based entirely on the highly conserved nature of the sequences 5'
to the other two in-frame methionines in the avian clone and the
sequences of mouse Gall and bovine GLa2. Though Nakamura
et al. [19] had not considered the first ATG as a likely initiation
codon for translation of GLa2, the first six amino acids present
in B4 are identical with those in mouse Gall and bovine GLa2.
Although the codons for these first six amino acids are conserved
in all three cDNA sequences, we were unable to obtain N-
terminal sequence from our purified protein, and as such have
not confirmed that these six amino acids are present. On the basis
of these sequence similarities, we conclude that clone B4 encodes
a protein that is the avian equivalent of Gail. As with other
members of this family [10], the lack of a cysteine at position 356
indicates that this protein would not be a substrate for pertussis
toxin. G-protein-stimulated phospholipase C activity in turkey
erythrocytes is insensitive to the effects of pertussis toxin.
The availability of cDNA encoding avian Gall has allowed a
direct comparison with the peptide sequence obtained from the
purified avian phospholipase C-activating protein. Peptides 1-8
contain amino acid sequences that were identical with amino
acids 78-92, 121-133, 159-171, 172-180, 253-256, 307-312,
339-345 and 355-359 of the deduced amino acid sequence of
cDNA B4. The sequence generated by peptides 3 and 4 is very
similar to the region in Gall against which antiserum E976 was
generated [18]. Peptide 2 represents the region in avian Gall that
corresponds to the Gaq sequence to which antiserum W082 was
raised. Since avian Gall and mammalian Gaq share only 69%
identity in this region, it is perhaps not surprising that antiserum
W082 reacts only very weakly with the purified avian protein.
From the complete amino acid identity of the peptide sequence
with that predicted from the avian Gall cDNA clone, we conclude
that the purified 43 kDa turkey phospholipase C-activating
protein is Gail.
Although extensive analyses have not been carried out, the
avian Gall cDNA has been successfully expressed in a baculo-
virus insect-cell (Sf'9) expression system. The expressed protein is
recognized by antibodies 118 and E976 (results not shown).
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Cholate extracts of membranes from recombinant Gal, baculo-
virus-infected Sf9 cells markedly stimulated the purified avian
phospholipase C in an A1F4--dependent manner after co-
reconstitution in substrate-containing phospholipid vesicles
(Table 1). Cholate extracts from Sf9 cells infected with a ,-
galactosidase-expressing recombinant baculovirus did not con-
tain significant amounts of protein that reacted with antiserum
118 (results not shown) and only activated the avian phos-
pholipase C to a very small extent (Table 1).
In summary, purification of the components of the avian G-
protein-regulated phospholipase C from a single homogeneous
cell preparation eliminates complexities inherent in assessing the
interactions between proteins purified from heterologous cell or
tissue preparations in different species. Using this approach, we
believe that we have purified and cloned the G-protein involved
in the regulation of phospholipase C in turkey erythrocytes and
have unequivocally demonstrated that it is an avian homologue
of Gail. Gall has high sequence similarity with Gaq, and it is
now clear that both proteins can activate phospholipase C
[3-7,17,18,20-22]. However, it is not clear if they express different
regulatory properties or interact with additional or different
effector proteins. The availability of purified avian Gall of
defined composition as well as recombinant Gall will allow us to
begin to address some of these and other questions.
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